Figure 1.
Flow chart depicting intervening lines of therapy between CAR T-cell therapy and allogeneic hematopoietic cell transplantation. Ab: antibody; alloHCT: allogeneic hematopoietic cell transplantation; CAR T: chimeric antigen receptor T-cell therapy; CR: complete remission; len: lenalidomide; n: number; NK: natural killer cell; ORR: overall response rate; PD-1: programmed cell death protein 1.